Andrew Weisenfeld of MTS Health Partners breaks down the healthcare bank’s growth plans after advising on Pfizer’s $43 billion acquisition of Seagen.
Powered by WPeMatico
Andrew Weisenfeld of MTS Health Partners breaks down the healthcare bank’s growth plans after advising on Pfizer’s $43 billion acquisition of Seagen.
Powered by WPeMatico